Dopamine depletion and in vivo binding of PET D1 receptor radioligands: implications for imaging studies in schizophrenia - PubMed (original) (raw)
Comparative Study
. 2003 Sep;28(9):1703-11.
doi: 10.1038/sj.npp.1300224. Epub 2003 Jun 18.
Affiliations
- PMID: 12813475
- DOI: 10.1038/sj.npp.1300224
Comparative Study
Dopamine depletion and in vivo binding of PET D1 receptor radioligands: implications for imaging studies in schizophrenia
Ningning Guo et al. Neuropsychopharmacology. 2003 Sep.
Abstract
Recent positron emission tomography (PET) studies have assessed the level of dopamine (DA) D1 receptors in the prefrontal cortex (PFC) in patients with schizophrenia and have generated contradictory findings. In the PFC of patients with schizophrenia, the binding potential (BP) of [11C]NNC 112 has been reported as increased, while the BP of [11C]SCH 23390 was reported as decreased or unchanged. In this study, the effect of acute and subchronic DA depletion on the in vivo binding of [11C]NNC 112 and [3H]SCH 23390 was evaluated in rats. Acute DA depletion did not affect [11C]NNC 112 in vivo binding, but paradoxically decreased [3H]SCH 23390 in vivo binding. Subchronic DA depletion was associated with increased [11C]NNC 112 in vivo binding and decreased [3H]SCH 23390 in vivo binding. Together, these data demonstrate that the in vivo binding of these radiotracers is differentially affected by changes in endogenous DA tone, and suggest that alterations in the binding of these tracers in the PFC of patients with schizophrenia might reflect changes in D1 receptors secondary to sustained deficit in prefrontal DA function.
Similar articles
- PET studies of binding competition between endogenous dopamine and the D1 radiotracer [11C]NNC 756.
Abi-Dargham A, Simpson N, Kegeles L, Parsey R, Hwang DR, Anjilvel S, Zea-Ponce Y, Lombardo I, Van Heertum R, Mann JJ, Foged C, Halldin C, Laruelle M. Abi-Dargham A, et al. Synapse. 1999 May;32(2):93-109. doi: 10.1002/(SICI)1098-2396(199905)32:2<93::AID-SYN3>3.0.CO;2-C. Synapse. 1999. PMID: 10231129 - Carbon-11-NNC 112: a radioligand for PET examination of striatal and neocortical D1-dopamine receptors.
Halldin C, Foged C, Chou YH, Karlsson P, Swahn CG, Sandell J, Sedvall G, Farde L. Halldin C, et al. J Nucl Med. 1998 Dec;39(12):2061-8. J Nucl Med. 1998. PMID: 9867142 - PET examination of [11C]NNC 687 and [11C]NNC 756 as new radioligands for the D1-dopamine receptor.
Karlsson P, Farde L, Halldin C, Swahn CG, Sedvall G, Foged C, Hansen KT, Skrumsager B. Karlsson P, et al. Psychopharmacology (Berl). 1993;113(2):149-56. doi: 10.1007/BF02245691. Psychopharmacology (Berl). 1993. PMID: 7855175 Clinical Trial. - Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia.
Abi-Dargham A, Moore H. Abi-Dargham A, et al. Neuroscientist. 2003 Oct;9(5):404-16. doi: 10.1177/1073858403252674. Neuroscientist. 2003. PMID: 14580124 Review. - Clozapine: dopamine D1 receptor agonism in the prefrontal cortex as the code to decipher a Rosetta stone of antipsychotic drugs.
Ahlenius S. Ahlenius S. Pharmacol Toxicol. 1999 May;84(5):193-6. doi: 10.1111/j.1600-0773.1999.tb01482.x. Pharmacol Toxicol. 1999. PMID: 10361974 Review.
Cited by
- A receptor-based model for dopamine-induced fMRI signal.
Mandeville JB, Sander CYM, Jenkins BG, Hooker JM, Catana C, Vanduffel W, Alpert NM, Rosen BR, Normandin MD. Mandeville JB, et al. Neuroimage. 2013 Jul 15;75:46-57. doi: 10.1016/j.neuroimage.2013.02.036. Epub 2013 Mar 1. Neuroimage. 2013. PMID: 23466936 Free PMC article. - Cortical Dopamine Transmission as Measured with the [11C]FLB 457 - Amphetamine PET Imaging Paradigm Is Not Influenced by COMT Genotype.
Narendran R, Tumuluru D, May MA, Chowdari KV, Himes ML, Fasenmyer K, Frankle WG, Nimgaonkar VL. Narendran R, et al. PLoS One. 2016 Jun 20;11(6):e0157867. doi: 10.1371/journal.pone.0157867. eCollection 2016. PLoS One. 2016. PMID: 27322568 Free PMC article. Clinical Trial. - In vivo binding of the dopamine-1 receptor PET tracers [¹¹C]NNC112 and [¹¹C]SCH23390: a comparison study in individuals with schizophrenia.
Poels EM, Girgis RR, Thompson JL, Slifstein M, Abi-Dargham A. Poels EM, et al. Psychopharmacology (Berl). 2013 Jul;228(1):167-74. doi: 10.1007/s00213-013-3026-8. Epub 2013 Mar 5. Psychopharmacology (Berl). 2013. PMID: 23460265 - Imaging cortical dopamine D1 receptors using [11C]NNC112 and ketanserin blockade of the 5-HT 2A receptors.
Catafau AM, Searle GE, Bullich S, Gunn RN, Rabiner EA, Herance R, Radua J, Farre M, Laruelle M. Catafau AM, et al. J Cereb Blood Flow Metab. 2010 May;30(5):985-93. doi: 10.1038/jcbfm.2009.269. Epub 2009 Dec 23. J Cereb Blood Flow Metab. 2010. PMID: 20029452 Free PMC article. - Prefrontal dopamine D1 receptors and working memory in schizotypal personality disorder: a PET study with [¹¹C]NNC112.
Thompson JL, Rosell DR, Slifstein M, Girgis RR, Xu X, Ehrlich Y, Kegeles LS, Hazlett EA, Abi-Dargham A, Siever LJ. Thompson JL, et al. Psychopharmacology (Berl). 2014 Oct;231(21):4231-40. doi: 10.1007/s00213-014-3566-6. Epub 2014 Apr 30. Psychopharmacology (Berl). 2014. PMID: 24781514 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous